Last reviewed · How we verify
NCT07159776: LEGEND-IBD
Multiple Digital Biomarkers for Optimization of IBD Care
trial testing monitoring of wearable data, shopping data, biomarkers and patient reported outcomes in Crohn Disease (CD) in 80 participants. Not yet recruiting.
30 September 2026
Quick facts
| Lead sponsor | Imelda GI Clinical Research Center |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 8 September 2025 |
| Primary completion | 30 September 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- monitoring of wearable data, shopping data, biomarkers and patient reported outcomes
Conditions studied
- Crohn Disease (CD) — all drugs for Crohn Disease (CD) →
- Ulcerative Colitis (UC) — all drugs for Ulcerative Colitis (UC) →
- Inflammatory Bowel Disease (IBD) — all drugs for Inflammatory Bowel Disease (IBD) →
Sponsor
Imelda GI Clinical Research Center
Who can join
18 and older, any sex, with Crohn Disease (CD) or Ulcerative Colitis (UC). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To develop digital biomarkers associated with disease activity of inflammatory bowel disease
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07159776
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Crohn Disease (CD)
Currently open trials in the same condition.
- NCT07510191 — TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response · Phase 4 · recruiting
- NCT07245394 — Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD) · recruiting
- NCT07224113 — Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD · recruiting
- NCT07170462 — Cranberry and Gut Health in Crohn's Disease · EARLY_PHASE1 · recruiting
- NCT07195123 — Evaluation of the SMART IBD App in Pediatric IBD · NA · recruiting
Other Imelda GI Clinical Research Center trials
Trials by the same sponsor.
- NCT04990245 — pAtient rePorted Outcomes Linked With histoLogy in Patients With uLcerative cOlitis · completed
- NCT04775732 — Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07159776 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Imelda GI Clinical Research Center
- Last refreshed: 8 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07159776.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing